A new paper has been published In Cardiovascular Research by the Lakhal-Littleton Group. In this translational study, the Lakhal-Littleton Group and their collaborators investigate the relationship between iron status and outcomes of myocardial infarction. In patients, they found that low circulating iron at admission independently predicts lower risk of major adverse cardiovascular events (MACE), such as heart failure, over 4.5 year follow-up. In mice, the researchers show that dietary iron restriction prior to myocardial infarction reduces the risk of progression to heart failure in the weeks that follow. Mechanistically, clinical and preclinical data support a role of iron in amplifying myocardial injury post MI.
These discoveries caution against iron supplementation in patients with acute myocardial infarction, and point to iron chelation as a therapeutic strategy to limit myocardial injury and improve long-term outcomes.